Bumetanide for thinking skills in Down syndrome
Treatments studied
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether a medication called bumetanide can improve thinking and learning skills in teenagers with Down syndrome. It is a 10-week study that compares bumetanide to a placebo (a pill with no medicine).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have Down syndrome (trisomy 21), confirmed by a genetic test.
- Your child must be between 10 and 17 years old.
- Your child's mental age (thinking abilities) should be between 4.5 and 8.5 years, as measured by a special test.
- Your child must not have epilepsy or serious hearing/vision problems.
- Your child cannot be taking water pills (diuretics) or have certain heart, kidney, or liver conditions.
- Your child and their parents must agree to participate, with parents signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive brain stimulation technique to help adolescents and young adults with Down syndrome improve their language skills. It aims to see if this safe method can boost word-finding and speaking ability.
This study tests whether a medicine called memantine (already used for memory problems) can help people with Down syndrome think and remember better. Researchers will try different doses to find what works best and is safest.
This trial studies whether a GnRH hormone treatment can improve thinking and memory in people with Down syndrome. It also checks safety and whether the treatment affects brain-related changes seen on MRI.
This study enrolls adults with Down syndrome to better understand how thinking and memory develop and change over time. It may help by building a “trial-ready” group and by measuring thinking in a careful, consistent way.
This trial tests a brain stimulation approach aimed at affecting brain activity in people with Down syndrome. It may help researchers understand whether this kind of stimulation can improve certain brain or thinking-related outcomes.
This study looks at how well a brain chemical system works in adults with Down syndrome as they age, including how it relates to Alzheimer’s-type brain changes and thinking skills. It uses brain scans and memory/thinking tests to see whether these measures can help track risk or changes over time.
Hear when a new Down Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.